Investigations of myelin oligodendrocyte glycoprotein (MOG) antibodies are usually focused on demyelinating syndromes, but the entire spectrum of MOG antibody-associated syndromes in children is unknown. In this study, we aimed to determine the frequency and distribution of paediatric demyelinating and encephalitic syndromes with MOG antibodies, their response to treatment, and the phenotypes associated with poor prognosis.
Vuoi saperne di più?
Accedi o registrati per accedere a tutti i contenuti di Neurodiem.
Hai già un account? Accedi
© 2019 Elsevier Ltd. All rights reserved.